Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Chubb
AstraZeneca
Moodys
Fuji
Express Scripts
Federal Trade Commission
Novartis
Cipla
Daiichi Sankyo

Generated: October 24, 2017

DrugPatentWatch Database Preview

TPN ELECTROLYTES IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Tpn Electrolytes In Plastic Container, and when can generic versions of Tpn Electrolytes In Plastic Container launch?

Tpn Electrolytes In Plastic Container is a drug marketed by Hospira and Abbott and is included in two NDAs.

The generic ingredient in TPN ELECTROLYTES IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride. There are two hundred and seventy drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
TPN ELECTROLYTES IN PLASTIC CONTAINER
calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride
INJECTABLE;INJECTION018895-001Jul 20, 1984RXYesYes► Subscribe► Subscribe► Subscribe
Abbott
TPN ELECTROLYTES IN PLASTIC CONTAINER
calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride
INJECTABLE;INJECTION019399-001Jun 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Merck
McKesson
Johnson and Johnson
Federal Trade Commission
Fuji
Daiichi Sankyo
Argus Health
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot